Helen A. Papadaki M.D., Ph.D. is Professor of Clinical Haematology at the University οf Crete (UoC), Greece and she is currently Head of the Department of Haematology of the University Hospital of Heraklion, Head of the Haemopoiesis Research Laboratory of the UoC and Head of the Public Umbilical Cord Blood Bank of the University Hospital of Heraklion/UoC. She is councillor on the European Haematology Association (EHA) Board and member of the Expert Committee for the approval of the biologic and blood-derived cellular products and the Advanced Therapy Medicinal Products (ATMP) of the National Organization for Medicines.
Dr. Papadaki received her medical degree from the University of Athens with honours and her PhD from the UoC. She has been trained in Internal Medicine and Haematology at the UoC and has been post-Doc researcher (EMBO fellowship) in Saint George’s Medical School, London, UK, visiting scientist at the Institute for Cancer Studies, Birmingham, UK and visiting physician at the Department of Haematology, University of Washington, Seattle, USA.
Dr Papadaki has been appointed Deputy Rector for Academic Affairs of the UoC (2013-2015).
Dr Papadaki’s main field of interest is Neutropenia, MDS and Mesenchymal Stem Cells (MSCs). Her research is focused on the role of immune mechanisms in the suppression of granulopoiesis/haemopoiesis, the implication of MSCs in the pathophysiology of BM failure and the use of MSCs in regenerative medicine. She has chaired the EHA SWG of Granulocyte/Monocyte Disorders and is currently member of the steering committee. She has also chaired the SWG of MDS/BM Failure Syndromes of the Hellenic Society of Haematology. She is a member of EHA, ASH and national medical societies.
Dr Papadaki has more than 150 original publications in international peer reviewed Journals, has more than 3000 citations and has been Principal Investigator in a number of national and international research grants.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.